Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A simple mathematical model of the chest wall was constructed so that during tidal breathing the relative volume contributions of the rib
cage
and abdomen/diaphragm could be measured in man, using four
mercury
-in-rubber strain gauges around the trunk. From the dimensions of the trunk and the change in circumference determined by the four gauges, the separate contributions of rib
cage
and abdomen/diaphragm could be determined using a purpose-built analog computer. The system was evaluated in 13 laboratory personnel, and in 13 other subjects before and after anaesthesia. There was a linear relationship between tidal volumes computed and measured at the mouth, over the residual volume to (FRC + 1 litre) range, with an error of +/- 8%. The relative contribution of rib
cage
to tidal breathing showed a large scatter from 5 to 42% with a non-significant tendency to decrease with age.
...
PMID:Measurement of the relative contributions of rib cage and abdomen/diaphragm to tidal breathing in man. 44 40
Female monkeys were dosed with 0, 10, 25 or 50 micrograms/kg/day of
mercury
as methylmercuric chloride. When blood levels reached equilibrium, females were bred to untreated males. A total of 5, 1, 2, and 5 live infants were born in the four dose groups, respectively. Infants were separated from their mothers at birth, and dosed with the same dose their mothers had received. Maternal blood
mercury
levels averaged 0.33, 0.78, or 1.41 ppm for the three dosed groups respectively. Infant blood
mercury
levels averaged 0.46, 0.93, or 2.66 ppm at birth, and decreased slowly to steady state levels of 0.20, 0.25, or 0.60 ppm. Behavior was assessed during infancy on a nonspatial discrimination reversal task and fixed interval performance, and when monkeys were juveniles on a series of nonspatial discrimination reversal tasks. During infancy monkeys were tested 7 days per week, 16-21 hr per day in a home-
cage
environment. As juveniles, they were tested five days per week in a standard operant test environment. For the discrimination reversal tasks, there were no strong indications of differences between treated and control monkeys either as infants or juveniles. Treated monkeys tended to perform transiently better than controls when first introduced to the task both as infants and juveniles. On the Fl, treated monkeys received more reinforcements, and had shorter pauses and lower quarter-life values than control monkeys. Analysis of feeding behavior over the session during infancy revealed marginally longer periods of feeding in methylmercury-treated infants. These results suggest that pre-plus postnatal exposure to methylmercury did not result in gross intellectual impairment in these monkeys, but may have interfered with temporal discrimination.
...
PMID:Effects of pre- plus postnatal exposure to methylmercury in the monkey on fixed interval and discrimination reversal performance. 143 60
Five monkeys (Macaca fascicularis) were dosed from birth to 6.5-7.0 years of age with 50 micrograms/kg/day of
mercury
as methylmercuric chloride. Blood
mercury
levels were 0.6-0.9 ppm throughout most of the period of dosing. Blood
mercury
levels declined rapidly after cessation of dosing to levels below 0.01 ppm. When these monkeys were approximately 13 years old, some individuals displayed clumsiness during routine exercise. This observation was examined by
cage
-side observation and independent clinical neurological assessment by two staff veterinarians. Fine motor performance was assessed by timing retrieval of raisins from recessed grids. Treated monkeys took longer to retrieve raisins than age-matched controls. Clinical neurological assessment revealed apparent insensitivity to touch and pin-prick in
mercury
-exposed monkeys, and exposed monkeys were clumsier and slower in the exercise
cage
. These results indicate that overt signs of toxicity can be manifested long after exposure to methylmercury has ceased.
...
PMID:Delayed neurotoxicity in monkeys exposed developmentally to methylmercury. 256 38
The timing of prephonatory movements of the larynx, rib
cage
, and abdomen was examined in order to gain insight into the contribution of the vocal folds to the posturing of the chest wall. A simple stimulus-response paradigm was used in eliciting brief utterances--/a/ and /ha/--from six adult males. Chest wall movements were observed using
mercury
strain gages while simultaneous electroglottographic and airflow records provided information about vocal fold behavior. Independence of prephonatory laryngeal and chest wall behavior was demonstrated. Laryngeal adjustment preceded the start of vocal fold oscillation by a constant amount of time, whereas the time of onset of the chest wall adjustment varied as a function of the utterance type. The qualitative characteristics of prephonatory chest wall posturing were unaffected by altering glottal configuration requirements. Rib
cage
enlargement occurred during postural adjustment while the vocal folds were abducted (in preparation for /h/). This implies that rib
cage
enlargement during prephonatory chest wall posturing was not a passive response to abdominal compression.
...
PMID:Prephonatory laryngeal and chest wall dynamics. 398
Previous studies have demonstrated that the anesthetic amine, chlorpromazine hydrochloride (CPZ), prevents cell necrosis in experimentally induced ischemic liver and heart disease and decreases the extent of galactosamine-induced cell death in the liver. The present model was designed to determine whether CPZ exerts a similar beneficial effect in kidney in a nephrotoxic model of acute renal failure in rats induced by the administration of mercuric chloride (2 mg/kg of body weight). The functional and structural changes in the kidney were evaluated and quantitated in animals pretreated with CPZ (40 mg/kg of body weight) or saline and then subjected to nephrotoxic injury. Compared to controls, the glomerular filtration rate was significantly lower (p less than 0.001) in saline- and CPZ-pretreated rats receiving mercuric chloride. Twenty-four hours after mercuric chloride administration the glomerular filtration rate was 446 +/- 38 microl/minute/gm of kidney weight, the fractional sodium excretion was 0.4 +/- 0.2%, and the urinary osmolality was 1440 +/- 193 mOsmoles/kg of H2O in the CPZ-treated animals compared to 26 +/- 18 microl/minute/gm of kidney weight (p less than 0.001), 10.1 +/- 9.8% (p less than 0.025), and 353 +/- 28 mOsmoles/kg of H2O (p less than 0.005), respectively, in the animals receiving mercuric chloride alone. The percentage of proximal tubule cell necrosis was 26.5 +/- 8.9% in the CPZ-pretreated group compared to 88.1 +/- 3.6% in the untreated group (p less than 0.001). Metabolic
cage
studies were performed to follow the time course of this model for 48, 72, and 96 hours after
mercury
injection. The serum creatinine values and fractional sodium excretions were significantly less in animals receiving CPZ compared to the untreated group at all time intervals examined. The serum urea nitrogen concentration and glomerular filtration rate were similar for the two groups after 48 hours, but the serum urea nitrogen level was significantly lower and the glomerular filtration rate higher after 72 and 96 hours in the animals pretreated with CPZ. In agreement with these findings were observations that animals pretreated with CPZ had significantly fewer necrotic cells 48 and 72 hours after
mercury
administration, and tubular regeneration appeared to be markedly accelerated. These results suggest that pretreatment with CPZ markedly lessens the degree of structural and functional impairment seen in mercuric chloride-induced acute renal failure in rats and increases the rate of recovery.
...
PMID:Partial protection by chlorpromazine in mercuric chloride-induced acute renal failure in rats. 623 24
This study was designed to correlated autopsy findings with the effects on
cage
behavior, laboratory values, and
mercury
clearance of long-term, low-dose exposure of primates to methylmercury. Six rhesus monkeys were given daily methylmercury hydroxide (MeHg) orally in apple juice on a preplanned dosage schedule. Three were sacrificed while receiving MeHg (group I) and the other 3 were sacrificed 2-5 mo after cessation of MeHg administration (group II). Whole-blood Hg levels (organic and inorganic) were assayed weekly, and major organ levels were assayed at autopsy. Whole-blood Hg levels were maintained between 1 and 2 micrograms/ml when the monkeys were given a MeHg dose of 80-125 micrograms/kg . d for up to 1 yr. The Hg burden of the major organs appeared to be dose- and duration-related. After periods of clearance (2.5-5 mo), intestinal wall Hg burden decreased to less than 1 microgram/g, and the hepatic Hg burden was still between 1.12 and 2.37 micrograms/g. However, the kidneys had a higher concentration of Hg, ranging from 10.34 to 29.54 micrograms/g. Whenever there was a high concentration of Hg, significant ultrastructural changes were observed. In the kidneys there were intracytoplasmic vacuoles and electron-dense inclusion bodies. In the small intestine of the animals cleared of
mercury
(group II), there were normal Paneth cells, as well as some degenerative cells characterized by dilation of endoplasmic reticulum and the presence of intracellular inclusion bodies. These findings suggest the long turnover time of Hg in these cell populations. During the period of study, weekly routine laboratory data including hematology, blood chemistry, and liver and kidney function tests did not reveal any significant changes.
...
PMID:Biochemical and morphological studies of monkeys chronically exposed to methylmercury. 665 43
Rats were fed on diets containing methyl
mercury
dicyandiamide (MMD) at concentrations of 1.5, 7.5 or 75 ppm, and observations made of their social and exploratory behaviour and of gross neurotoxicity (ataxia).
Mercury
concentration in the blood was monitored. MMD at 75 ppm (50 ppm Hg) for 24 days caused ataxia with a sudden onset at 21-27 days. Social behaviour was reduced at 16-17 days. In two experiments at 7.5 ppm MMD, activity was increased in observations of social behaviour after 2 to 17 days, and treated rats found water in an unfamiliar
cage
sooner than controls. No difference from controls was apparent from then until increased activity re-appeared after 9 mon of the diet (exp. 1) or after 7 days recovery from 31 or 45 days diet (exp. 2). Ataxia was not observed after 7.5 ppm MMD for up to 47 weeks or in 14 weeks recovery. No consistent effect was observed at 1.5 ppm MMD for 31-45 days. MMD, therefore, had a behavioural effect in rats, independent of gross neurotoxicity; its details were consistent with a hyperresponsiveness to stimuli. Tolerance occurred to this effect at a time when blood-
mercury
concentration was still rising, but the tolerance appeared to be subject to overload.
...
PMID:Early change and adaptation in the social behaviour or rats given methyl mercury in the diet. 719 56
Flumazenil, a benzodiazepine antagonist, reliably reverses midazolam-induced sedation, but its effect on respiratory depression has not been clarified completely. Ten healthy male volunteers received midazolam 0.1 mg.kg-1. Then they received flumazenil 0.5 mg (n = 9) and 1.0 mg (n = 1), intravenously. Rib-
cage
(RC) and abdominal wall (ABD) movement was measured by
mercury
-in-silastic strain gauge. Nasal air flow (FLOW), genioglossal electromyogram (EMG) and oxygen saturation (SaO2) were recorded simultaneously. Midazolam caused significant increases of RC movement and respiratory rate, and decreases of ABD movement, FLOW, EMG and SaO2. After administration of flumazenil, although respiratory rate returned to the pre-midazolam values, RC movement decreased on the contrary. ABD movement, FLOW, EMG, SaO2 did not recover to the pre-midazolam values. These data suggest that flumazenil 0.5 mg reverses midazolam-induced sedation completely, but is partially effective for some parameters related to respiratory depression.
...
PMID:[Flumazenil antagonism of midazolam-induced respiratory depression]. 801 61
1. The normal interactions between respiration, mastication, and swallowing were studied in seated adult humans. Respiratory movements and movements of the larynx were recorded with
mercury
-elastic strain gauges placed around the rib
cage
and neck. A rigid body containing infrared-emitting diodes (IREDs) was attached to the forehead, and a single IRED was applied to the chin. Jaw and head movements were transduced using the OPTOTRAK spatial motion analysis system. Recordings were made before, during, and after the mastication of pieces of carrot. 2. Movements of the larynx were used as a marker for swallowing. Measurements were made of the duration of masticatory and respiratory cycles, and the phase relationship between the two rhythms was determined. Deviations in masticatory and respiratory movements during swallowing were detected; the phases of the masticatory and respiratory cycles in which the deviations occurred were determined, and the interval between each deviation and the swallowing marker was calculated. 3. Three characteristic swallowing patterns were observed: interposed, terminal, and spontaneous. Interposed swallows occurred within a masticatory sequence, terminal swallows ended the sequence, and spontaneous swallows occurred sporadically between masticatory sequences. 4. Results revealed that mastication could have a profound effect on the respiratory rhythm in some subjects. One subject, whose data were excluded from further analyses, became apneic for a long period, followed by short and shallow breaths near the end of the masticatory sequence. In most subjects, respiratory rate increased during mastication and then dropped below baseline as soon as mastication ended. The end-inspiration diameter of the rib
cage
tended to decrease in the preswallow period and increase postmastication relative to baseline. 5. There was a weak but significant tendency for inspiration to begin during the jaw opening phase of mastication, but phase coupling did not become stronger as swallowing was approached. 6. Deviations in respiration during swallowing occurred during the late expiratory phase of the breathing cycle. Swallows within a masticatory sequence occurred most frequently during the early opening phase of the masticatory cycle, and terminal swallows occurred after the end of the sequence with the mandible in the resting, postural position. Swallowing temporarily reset both the masticatory and respiratory rhythms. Most swallows prolonged the duration of one or two respiratory cycles, however; swallows were often repetitive, and in some subjects two or three swallows fell within a single respiratory cycle, prolonging it for several seconds. 7. A tight temporal relationship was observed between deviations in respiration and the swallowing marker: all deviations occurred before or coincident with the marker. The time of deviations in mastication relative to the swallowing marker depended on swallow type. There was no link between the start of pauses in the two rhythms, suggesting that the commands from the swallowing central pattern generator to the other two pattern generators are independent. 8. We suggest that disordered coordination of mastication and swallowing with respiration may cause prolonged apnea in susceptible individuals.
...
PMID:Modification of mastication and respiration during swallowing in the adult human. 898 89
Before, during, and after cardiac intervention, there is occasionally a need for circulatory support because of hemodynamic deterioration. For this purpose, a new minimally invasive cardiac assist device has been developed, and an early prototype has been studied in a bench test and in three pigs. The pump is a catheter system with a distal motor driven propeller (0-15,000 rpm) surrounded by a
cage
. The catheter was first tested in a tube in a water bath, where efficiency with respect to pressure generation and flow properties was measured. In the pig experiments, the pump was placed in the descending part of the aorta via a graft, and hemodynamic effects were recorded with three different propellers. The bench tests showed a velocity dependent pressure generation in the tube to the second power of the rpm, and 30 cm of water (> 22 mm Hg) could easily be achieved with all propellers. A pressure dependent flow in the tube was observed, with maximum flows of 20 L at 12,000 rpm and 27 L at 15,000 rpm. In the animal experiments, there was a velocity dependent mean pressure difference across the propeller, with up to 48 mm of
mercury
for the biggest propeller. An increase in cardiac output in all of the pigs was observed as well as a drop in pressure in the proximal part of the aorta. This study demonstrates the efficiency of this new device in vitro and in vivo. Hemodynamic changes are pronounced and are related to the speed and size of the propeller.
...
PMID:Initial tests with a new cardiac assist device. 1044 38
1
2
3
4
5
Next >>